Know Cancer

or
forgot password

Colorectal Cancer Screening in Average-risk Population: a Multicenter, Randomized Control Trial Comparing Immunochemical Fecal Occult Blood Testing Versus Colonoscopy.


Phase 3
50 Years
69 Years
Open (Enrolling)
Both
Colorectal Cancer, Colorectal Neoplasm

Thank you

Trial Information

Colorectal Cancer Screening in Average-risk Population: a Multicenter, Randomized Control Trial Comparing Immunochemical Fecal Occult Blood Testing Versus Colonoscopy.


Inclusion Criteria:



- Men and women aged 50-69 years

Exclusion Criteria:

- Personal history of colorectal cancer, colorectal adenoma, colorectal polyposis, or
inflammatory bowel disease

- Family history of colorectal polyposis, Lynch syndrome or familial colorectal cancer
(2 or more first-degree relatives diagnosed with colorectal cancer or one
first-degree relative diagnosed with colorectal cancer before the age of 60)

- Severe comorbidity

- Previous total colectomy

- Not signed informed consent to participate

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Screening

Outcome Measure:

Colorectal cancer-related mortality

Outcome Time Frame:

10 years

Safety Issue:

No

Principal Investigator

Antoni Castells, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Hospital Clínic, Barcelona, Spain

Authority:

Spain: Ethics Committee

Study ID:

COLONPREV

NCT ID:

NCT00906997

Start Date:

November 2008

Completion Date:

November 2021

Related Keywords:

  • Colorectal Cancer
  • Colorectal Neoplasm
  • Colorectal cancer
  • Screening
  • Prevention
  • Fecal occult blood test
  • Colonoscopy
  • Colorectal neoplasm
  • Randomized clinical trial
  • Neoplasms
  • Colorectal Neoplasms

Name

Location